Cel Sci Corporation (CVM)

[overlordpeter]

Cel-Sci Reports European Patent On Cancer Drug

08:17 AM EDT, 07/11/2016 (MT Newswires) -- Cel-Sci(CVM) Monday reported that it has been granted a new European Union patent covering its investigational phase 3 cancer drug leucocyte interleukin.

The drug "pre-sensitizes" cancer cells prior to radiation or chemotherapy, making the cells more vulnerable to treatment.

Cel-sci said the patent is titled, "A Method Of Pre-Sensitizing Cancer Prior To Treatment With Radiation and/or Chemotherapy And A Novel Cytokine Mixture," and is not limited to any one particular type of cancer.

Cel-Sci (CVM) noted that its ongoing phase 3 clinical trial in head and neck cancer patients is administering leucocyte interleukin therapy as part of a first-line treatment, before any other treatments and prior to surgery, followed by radiation or concurrent chemo-radiotherapy.

Price: 0.47, Change: , Percent Change:

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited